跳至主要内容
临床试验/NCT00706394
NCT00706394已完成不适用

Prospective, Multicenter, Single Arm Phase II Study of the Powerlink 34mm Cuff for the Endovascular Repair of Abdominal Aortic Aneurysms

Endologix10 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2007年8月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Endologix
入组人数
19
试验地点
10
主要终点
Number of Participants With Proximal Type I Endoleak at Each Timepoint

研究概览

简要总结

Study of anatomical fixation with a 34mm proximal extension

详细描述

The 34mm proximal extension stent graft is intended to augment the primary 28mm infrarenal bifurcated stent graft to accommodate patient anatomy (neck diameters up to 32mm) and provide an effective seal to prevent/repair proximal Type I endoleaks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 years old or older
  • •Informed consent understood and signed
  • •Will comply with protocol follow-up requirements
  • •Candidate for conventional open surgical repair
  • •Aneurysm outer diameter is one or more of the following:
  • •greater than or equal to 4.0cm
  • •greater than or equal to 3.0cm (saccular aneurysm)
  • •greater than or equal to twice the normal aortic outer diameter
  • •rapidly growing (greater than or equal to 5mm over 6 months)
  • •Proximal non-aneurysmal aortic neck fixation length greater than or equal to 1.5cm between the renal arteries and the aneurysm
  • •Non-aneurysmal proximal aortic neck inner diameter between 23 and 32mm
  • •Iliac artery internal diameter greater than or equal to 8 mm

排除标准

  • •Life expectancy <2 years
  • •Participating in another clinical study
  • •Pregnant or lactating women
  • •Acutely ruptured/leaking aneurysm
  • •Traumatic vascular injury
  • •Other medical or psychiatric problems
  • •Contraindication to non-ionic contrast media or anticoagulants
  • •Coagulopathy or bleeding disorder
  • •Active systemic or localized groin infection
  • •Indispensable inferior mesenteric artery
  • •Connective tissue disease (e.g., Marfan's Syndrome)
  • •Creatinine level >1.7 mg/dl
  • •Renal transplant patient
  • •Proximal attachment site >60º angle to the aneurysm body
  • •Iliac arteries >90º angle
  • •<1.5 cm of non-aneurysmal common iliac artery above the iliac bifurcation on both sides [One internal iliac artery is required to remain patent]
  • •Thrombus >30% at implantation site

研究组 & 干预措施

A

Experimental

Powerlink 34mm cuff stent graft

干预措施: Endologix Powerlink 34 mm stent graft cuff (Device)

结局指标

主要结局

Number of Participants With Proximal Type I Endoleak at Each Timepoint

时间窗: Five years

Percentage of patients with Type Ia endoleaks at each timepoint (discharge, 1, 6, 12, 24, 36, 48 and 60 months).

次要结局

  • Number of Participants With Type III Endoleaks at Each Timepoint(5 Years)
  • Maximum Diameter Measurements(5 Years)
  • Number of Participants With Aneurysm Diameter Change at Each Timepoint(5 Years)
  • Number of Participants With Migration at Each Timepoint(5 Years)
  • Aneurysm Volume Measurements(5 Years)
  • Number of Participants With Stent Fracture at Each Timepoint(5 Years)
  • Number of Participants With Stent Graft Obstruction at Each Timepoint(5 Years)
  • Number of Participants With Type II Endoleaks at Each Timepoint(5 Years)
  • Number of Participants With Successful Delivery and Deployment of the Device(1 Month)

研究者

发起方
Endologix
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验